Fig. 3
From: Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
Oncolytic activity of VG9-IL-24 in vitro. A The proliferation of VG9-EGFP in SMMC-7721 cells and HL-7702 cells. The viral replication was monitored under the fluorescence microscope after infection for 48 h. Bar: 20 μm. B VG9-IL-24 selectively replicated in tumor cells. HCC cells and HL-7702 cells in 12-well plates were infected with 0.1 MOI of VG9-IL-24 and samples were collected at 48 h. Each bar represents the mean ± SD (n = 3)